Baozun Inc.
BZUN
Positions held
Your positionsBZUN isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $188.83M | Enterprise value | $1.14B | Trailing P/E | 23.21 | Forward P/E | 3.73 |
| PEG | 0.06 | Price / book | 0.35 | Beta | 0.39 | Dividend yield | 0.00% |
| Revenue growth | 7.5% | Earnings growth | — | Gross margin | 52.7% | Operating margin | 2.3% |
| Profit margin | -1.3% | ROE | -1.2% | ROA | 0.9% | Debt / equity | 0.34 |
| Current ratio | 1.90 | Free cash flow | $606.40M | Analyst recommendation | none | Mean target | $4.60 |
| 52w high | $3.82 | 52w low | $2.07 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | |
|---|---|---|---|---|---|
| Revenue | $2.7B | $2.4B | $3.2B | $2.2B | $2.6B |
| Op margin | 2.3% | 0.0% | 6.1% | -1.2% | -0.4% |
| Net income | $17.0M | -$7.5M | -$38.0M | -$107M | -$34.0M |
| Gross margin | 55.1% | 49.0% | 53.7% | 52.4% | 48.4% |
| Gross profit | $1.5B | $1.2B | $1.7B | $1.1B | $1.2B |
| Operating income | $63.4M | $0.3M | $194M | -$25.6M | -$9.4M |
- Revenue +15% vs prior quarter ($2.7B vs $2.4B).
- Gross margin 55.1% (was 49% prior quarter).
- Operating margin expanded to 2.3%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $9.9B | $9.4B | $8.8B | $8.4B |
| Op margin | 0.8% | -1.1% | -1.9% | 0.6% |
| Net income | -$242M | -$185M | -$278M | -$653M |
| Gross margin | 50.9% | 47.6% | 44.2% | 40.8% |
| Gross profit | $5.1B | $4.5B | $3.9B | $3.4B |
| Operating income | $75.0M | -$108M | -$171M | $46.4M |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-08 · Asian Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading
2026-09-24 · Asian Equities Traded in the US as American Depositary Receipts Fall in Thursday Trading
2026-09-24 · Baozun Announces US$10 million Share Repurchase Program
2026-09-24 · Baozun Announces US$10 million Share Repurchase Program
2026-08-31 · Baozun (BZUN) Q2 2026 Earnings Call Transcript
2026-08-28 · Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Up 2% for Week
2026-08-28 · Moderna upgraded, Allstate downgraded: Wall Street's top analyst calls
2026-08-27 · Baozun Inc (BZUN) (Q2 2026) Earnings Call Highlights: Revenue Climbs 7% as AI and Brand ...
2026-08-27 · Asian Equities Traded in the US as American Depositary Receipts Head Slightly Lower in Thursday Trading
2026-08-27 · Baozun Q2 Earnings Call Highlights
2026-08-27 · Baozun shares rise as earnings beat forecasts and profitability improves
Price (daily)
Full chart · RSI · MACD · patterns